Lv72
4910 积分 2022-07-17 加入
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
11小时前
待确认
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
11小时前
求助中
Sex differences in the evolution of the electrocardiographic QT interval with age
11小时前
求助中
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
12小时前
求助中
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
10天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
10天前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
14天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
26天前
已完结
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
1个月前
已完结
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase Ⅲ -study from the German CONKO-study group
1个月前
已完结
皖公网安备34019202002308
